Captrust Financial Advisors Has $443,000 Stock Holdings in Azenta, Inc. (NASDAQ:AZTA)

Captrust Financial Advisors lessened its stake in shares of Azenta, Inc. (NASDAQ:AZTA) by 5.2% in the third quarter, according to the company in its most recent filing with the SEC. The fund owned 9,153 shares of the company’s stock after selling 502 shares during the quarter. Captrust Financial Advisors’ holdings in Azenta were worth $443,000 as of its most recent SEC filing.

A number of other hedge funds also recently modified their holdings of AZTA. Hantz Financial Services Inc. acquired a new stake in Azenta during the second quarter worth approximately $30,000. Farther Finance Advisors LLC lifted its holdings in Azenta by 20.0% during the 3rd quarter. Farther Finance Advisors LLC now owns 1,537 shares of the company’s stock worth $74,000 after purchasing an additional 256 shares during the last quarter. Benjamin F. Edwards & Company Inc. boosted its stake in Azenta by 150.9% in the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 1,588 shares of the company’s stock valued at $84,000 after purchasing an additional 955 shares during the period. Net Worth Advisory Group acquired a new position in Azenta in the 3rd quarter valued at $205,000. Finally, Aigen Investment Management LP acquired a new position in Azenta in the 3rd quarter valued at $214,000. Institutional investors and hedge funds own 99.08% of the company’s stock.

Wall Street Analyst Weigh In

AZTA has been the subject of a number of recent research reports. Needham & Company LLC reduced their target price on shares of Azenta from $69.00 to $55.00 and set a “buy” rating for the company in a research report on Wednesday, November 13th. Evercore ISI cut their price objective on shares of Azenta from $53.00 to $50.00 and set an “in-line” rating for the company in a report on Tuesday, October 1st. Three analysts have rated the stock with a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $63.60.

Azenta Price Performance

Shares of NASDAQ AZTA opened at $45.94 on Friday. The stock has a market capitalization of $2.09 billion, a PE ratio of -15.47 and a beta of 1.49. The business has a fifty day moving average price of $44.60 and a two-hundred day moving average price of $49.58. Azenta, Inc. has a fifty-two week low of $38.82 and a fifty-two week high of $69.16.

Azenta (NASDAQ:AZTA) last posted its quarterly earnings results on Tuesday, November 12th. The company reported $0.18 EPS for the quarter, beating analysts’ consensus estimates of $0.10 by $0.08. The business had revenue of $170.00 million during the quarter, compared to the consensus estimate of $169.66 million. Azenta had a positive return on equity of 1.03% and a negative net margin of 25.01%. Azenta’s revenue for the quarter was down 1.2% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.13 earnings per share. On average, equities analysts expect that Azenta, Inc. will post 0.41 EPS for the current year.

Insider Activity

In other Azenta news, CEO John Marotta bought 12,717 shares of the stock in a transaction on Monday, November 18th. The stock was purchased at an average price of $39.48 per share, with a total value of $502,067.16. Following the completion of the purchase, the chief executive officer now owns 99,612 shares in the company, valued at $3,932,681.76. The trade was a 14.63 % increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available through the SEC website. Also, CFO Herman Cueto sold 1,595 shares of the business’s stock in a transaction dated Thursday, October 17th. The stock was sold at an average price of $43.68, for a total value of $69,669.60. Following the transaction, the chief financial officer now directly owns 24,604 shares of the company’s stock, valued at approximately $1,074,702.72. The trade was a 6.09 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 3,018 shares of company stock worth $126,689. 1.77% of the stock is currently owned by corporate insiders.

About Azenta

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.